Prism Medico & Pharmacy
PRISMMEDICOPHARMACYLTD NSE
Prism Medico & Pharmacy
Financial ServicesNSE: PRISMMEDICOPHARMACYLTD BSE: 512217 NBFC
Key Fundamentals
MicrocapNBFCFinancial ServicesMarket Cap
₹40.63 Cr
Volatility
Moderate
P/E Ratio
-102.6
EBITDA
₹0.40 Cr
Return on Equity
0.31%
Debt to Equity
0.17
Book Value
₹16.89
EPS
₹0
52W High
₹34.49
52W Low
₹15.51
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company is almost debt free.
- Stock is trading at 1.17 times its book value
Weaknesses
4- Company has low interest coverage ratio.
- Promoter holding is low: 30.0%
- Company has a low return on equity of 0.55% over last 3 years.
- Company has high debtors of 595 days.
Growth Rate
Revenue Growth
140% higher than
3Y
Net Income Growth
-156% lower than
3Y
Cash Flow Change
-112% lower than
3Y
ROE
—
ROCE
-97.09% higher than
3Y
EBITDA Margin (Avg.)
-79.55% lower than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0.03 | 2.75 | 0.15 | 0.06 | 0.29 | 0.21 | 0.07 | 1.59 | 0.5 | 0.07 | 0.28 | 0 |
| Expenses | 0.11 | 0.09 | 2.56 | 0.32 | 0.15 | 0.28 | 0.22 | 0.06 | 0.94 | 0.6 | 0.09 | 0.4 | 0.15 |
| Financing Profit | -0.11 | -0.06 | 0.19 | -0.17 | -0.09 | 0.01 | -0.01 | 0.01 | 0.65 | -0.1 | -0.02 | -0.12 | -0.15 |
| Fin. Margin % | — | -200% | 6.91% | -113.33% | -150% | 3.45% | -4.76% | 14.29% | 40.88% | -20% | -28.57% | -42.86% | — |
| Other Income | 0.02 | 0.01 | 0 | 0.1 | 0 | 0 | 0 | 0.01 | 0 | 0.02 | 0.01 | 0 | 0.09 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | -0.09 | -0.05 | 0.19 | -0.07 | -0.09 | 0.01 | -0.01 | 0.02 | 0.65 | -0.08 | -0.01 | -0.12 | -0.06 |
| Tax % | 0% | 0% | 0% | -14.29% | 0% | 0% | 0% | -100% | -1.54% | 0% | 0% | 100% | 0% |
| Net Profit | -0.09 | -0.05 | 0.19 | -0.07 | -0.09 | 0.01 | -0.01 | 0.04 | 0.66 | -0.08 | -0.01 | -0.24 | -0.06 |
| EPS in Rs | -0.15 | -0.08 | 0.31 | -0.12 | -0.15 | 0.02 | -0.02 | 0.07 | 1.09 | -0.13 | -0.02 | -0.4 | -0.04 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0.09 | 0.09 | 20.96 | 36.31 | 26.89 | 16.76 | 8.44 | 1.27 | 2.93 | 0.63 | 2.41 | 0.85 |
| Expenses | 0.06 | 0.15 | 0.37 | 20.86 | 35.98 | 26.94 | 16.92 | 8.93 | 1.37 | 3.06 | 0.71 | 2.01 | 1.24 |
| Financing Profit | -0.06 | -0.06 | -0.28 | 0.1 | 0.33 | -0.05 | -0.16 | -0.49 | -0.1 | -0.14 | -0.08 | 0.4 | -0.39 |
| Fin. Margin % | — | -66.67% | -311.11% | 0.48% | 0.91% | -0.19% | -0.95% | -5.81% | -7.87% | -4.78% | -12.7% | 16.6% | -45.88% |
| Other Income | 0.06 | 0.06 | 0.07 | -0.01 | -0.01 | 0 | 0 | 0 | 0 | 0.12 | 0.02 | 0.03 | 0.12 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 |
| Depreciation | 0.01 | 0.01 | 0.02 | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 |
| PBT | -0.01 | -0.01 | -0.23 | 0.05 | 0.29 | -0.07 | -0.17 | -0.5 | -0.11 | -0.03 | -0.06 | 0.43 | -0.27 |
| Tax % | 0% | 0% | 0% | 140% | -24.14% | -28.57% | -29.41% | -26% | -27.27% | -33.33% | -33.33% | 25.58% | — |
| Net Profit | -0.01 | -0.01 | -0.23 | -0.02 | 0.37 | -0.05 | -0.13 | -0.37 | -0.08 | -0.02 | -0.05 | 0.32 | -0.39 |
| EPS in Rs | -0.05 | -0.05 | -0.38 | -0.03 | 0.61 | -0.08 | -0.21 | -0.61 | -0.13 | -0.03 | -0.08 | 0.53 | -0.59 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.99 | 1.99 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 | 6.06 |
| Reserves | -0.36 | -0.36 | 6.74 | 6.72 | 7.09 | 6.99 | 6.86 | 6.49 | 9.1 | 9.08 | 9.03 | 9.35 |
| Borrowing | 0.02 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.04 | 0.16 | 0.25 | 0.16 | 3.82 | 8.54 | 8.63 | 0.02 | 0.23 | 0.1 | 0.47 | 0.2 |
| Total Liabilities | 1.69 | 1.86 | 13.05 | 12.94 | 16.97 | 21.59 | 21.55 | 12.57 | 15.39 | 15.24 | 15.56 | 15.61 |
| Fixed Assets | 0.01 | 0 | 0.16 | 0.11 | 0.09 | 0.07 | 0.06 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 10 | 11.25 | 10 | 1.94 | 1.94 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1.68 | 1.86 | 2.89 | 1.58 | 6.88 | 19.58 | 19.55 | 12.52 | 15.36 | 15.21 | 15.53 | 15.58 |
| Total Assets | 1.69 | 1.86 | 13.05 | 12.94 | 16.97 | 21.59 | 21.55 | 12.57 | 15.39 | 15.24 | 15.56 | 15.61 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0.01 | 0.05 | -0.82 | -0.06 | -1.23 | -4.36 | -0.05 | -2.38 | 2.95 | -0.01 | -0.02 | 0 |
| Investing | 0 | 0.46 | 0.3 | -1.25 | 1.25 | 4.36 | 0.02 | 2.35 | -2.91 | 0 | 0 | 0 |
| Financing | 0.02 | 0.05 | 1.33 | -0.05 | 0.06 | 0 | 0 | 0 | 0 | -0.01 | 0 | 0 |
| Net Cash Flow | 0.02 | 0.56 | 0.81 | -1.36 | 0.08 | -0.01 | -0.03 | -0.03 | 0.04 | -0.01 | -0.02 | 0 |
| Free Cash Flow | 0.01 | 0.05 | -0.99 | -0.06 | -1.23 | -4.36 | -0.05 | -2.38 | 2.95 | -0.01 | -0.02 | 0 |
| CFO/OP | -17 | -83 | 293 | -50 | -355 | 8,660 | 31 | 486 | -3,220 | 8 | 25 | 0 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | -0.61% | -0.61% | -3.19% | -0.16% | 4.24% | -0.38% | -1% | -2.91% | -0.58% | -0.13% | -0.33% | 2.1% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Prism Medico & Pharmacy insights
56 extracted metrics + investor summaries across FY09–FY26.
Documents
1
Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015.
10h - Board on 11 May 2026 appointed Harpreet Singh, S Harpreet and Associates, as internal auditor for FY2025-26. 10h - Board on 11 May 2026 appointed Harpreet Singh, S Harpreet and Associates, as internal auditor for FY2025-26.
2
Board Meeting Outcome for Outcome Of Board Meeting For Allotment Of Securities
5 May - Board approved allotment of 75 lakh shares and 50 lakh warrants on preferential basis on May 5, 2026. 5 May - Board approved allotment of 75 lakh shares and 50 lakh warrants on preferential basis on May 5, 2026.
3
Announcement under Regulation 30 (LODR)-Allotment
5 May - Board approved allotment of 75 lakh shares and 50 lakh convertible warrants on May 5, 2026. 5 May - Board approved allotment of 75 lakh shares and 50 lakh convertible warrants on May 5, 2026.
4
Confirmation Regarding Non-Applicability Of Large Corporate Entity Framework.
29 Apr - Company confirmed it is not a large corporate entity as on 31 March 2026. 29 Apr - Company confirmed it is not a large corporate entity as on 31 March 2026.
5
Confirmation Regarding Non-Applicability Of Large Corporate Entity Framework.
29 Apr - Company confirmed it is not a large corporate entity as on 31 March 2026. 29 Apr - Company confirmed it is not a large corporate entity as on 31 March 2026.
Frequently Asked Questions about Prism Medico & Pharmacy
What does Prism Medico & Pharmacy Ltd do?
Incorporated in 1985, Prism Medico & Pharmacy Ltd manufactures, trades, and distributes chemicals, medicines, pharmaceuticals, cosmetics, and related products[1]
Where is Prism Medico & Pharmacy Ltd (512217) listed?
Prism Medico & Pharmacy Ltd trades as PRISMMEDICOPHARMACYLTD on the NSE and under code 512217 on the BSE.
Which sector does Prism Medico & Pharmacy Ltd belong to?
Prism Medico & Pharmacy Ltd is classified under the Financial Services sector, in the NBFC industry.
What is the market capitalisation of Prism Medico & Pharmacy Ltd?
Prism Medico & Pharmacy Ltd has a market capitalisation of ₹40.63 Cr, which places it in the Small Cap band.
What is the PE ratio of Prism Medico & Pharmacy Ltd?
Prism Medico & Pharmacy Ltd trades at a PE ratio of -102.60, on earnings per share of ₹0, against a book value of ₹16.89 per share.
What is the 52-week high and low of Prism Medico & Pharmacy Ltd?
Over the last 52 weeks Prism Medico & Pharmacy Ltd has traded between ₹15.51 and ₹34.49.
What is the Return on Equity (ROE) of Prism Medico & Pharmacy Ltd?
Prism Medico & Pharmacy Ltd reported a return on equity of 0.31%. Its debt-to-equity ratio is 0.17.
Company Information
Incorporated in 1985, Prism Medico & Pharmacy Ltd manufactures, trades, and distributes chemicals, medicines, pharmaceuticals, cosmetics, and related products[1]
Website prismmedicos.com
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/512217.md for Prism Medico & Pharmacy Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.